Decentralized Trials Archives

Fully Remote, Hybrid, or Flexible Hybrid Decentralized Trials

June 28, 2023

CROs and sponsors must consider multiple factors when deciding between a fully remote, hybrid or flexible hybrid approach for their clinical trial. Read up on the key considerations here!

Start with ‘Why’ When Adopting New Tech to Support Hybrid Decentralized Trials

September 30, 2022

Sponsors can reduce the burden of adopting new hybrid decentralized trial technology by explaining its relevance and taking steps to reduce the cost of change.

The The Future of RTSM: Insights and Forecasting with RTSM-Expert, Ian Davison:

April 5, 2022

By all expert accounts, 2022 is the year that we can begin seeing the societal shift from late-stage pandemic to early-stage endemic as the world learns to live with the short- and long-term effects of…

Think Paper is the Safe Choice for Your Studies? Think Again.

March 24, 2022

It’s 2022—the world is embracing digitalization on a mass scale, yet 76% of healthcare organizations admit to printing their consent forms on paper. Why does the clinical trials industry continue to think that paper forms are…

Why CTMS Is Critical As Trial Complexities Increase

November 9, 2021

The clinical trials industry is buckling under the weight of continuously growing complexities. Developing an interconnected clinical trials ecosystem will be essential to minimizing the ripple effects of complexity impacting your sites and patients. As…

How to Sustain Clinical Trial Patient Engagement

September 7, 2021

The process of bringing a new treatment to market can be a long, arduous journey. On average, it takes ten years for a treatment to travel all the way from clinical trials to market approval.1…

How eSource Optimizes The Clinical Site Experience

September 7, 2021

Trial sites are a cornerstone of clinical research but are often overloaded with a myriad of complex, manual, and time-sensitive tasks. How can sites be expected to create a positive patient experience, ensure safety and…

The Power of Patient-Centricity in Rare Disease Studies

September 6, 2021

Orphan drug discoveries promise unprecedented opportunities, as well as challenges. Unfortunately, research in the rare disease space presents some of the highest hurdles in medicine due to the nature of their small, complex patient populations.…

Can Your eClinical Empower Patients and Inform Stakeholders?

August 5, 2021

“People are experts in everyday living. Physicians are experts in clinical care. Technologies bring them together.” – Patricia Brennan, RN, Ph.D., FAAN, FACMI[1] As clinical research continues to struggle with recruitment and retention, it makes…

4 Reasons Decentralized Trials Are Here to Stay

July 6, 2021

Long before the global pandemic, clinical trial sponsors were consumed with accelerating their studies and improving the trial experience for key stakeholders. Decentralization emerged as a leading factor in this pursuit. As COVID-19 inundated healthcare…

How to Strengthen Trial Retention Through Patient Education

April 30, 2021

According to a 2019 CISCRP study, 85% of the general public are willing to participate in clinical trial research. Yet, recruitment continues to plague the industry as one of the most costly and timely…

Thank Technology: Oncology’s Golden Age Is Here

March 20, 2021

To my mom, sister, father-in-law, and late aunt, I promise this: The 2020s will be a breakthrough decade for oncology. For me, cancer isn’t some abstract concept. Multiple members of my family are alive today…

Diseases Don’t Discriminate. So Why Aren’t Clinical Trials More Diverse?

March 19, 2021

COVID-19 isn’t one tragedy, but many. An underreported tragedy is the outsized harm done to communities of color.In New York City — an early COVID-19 hotspot and one of the most diverse communities in the…

How Decentralized Trials Strengthen Your Participation Pool

March 16, 2021

Long before COVID-19, recruiting and retaining patients for clinical trials was a growing problem with 85% of all trials failing to recruit enough patients and 80% delayed due to recruitment problems and high drop-out rates.…

Hesitant to Embrace Decentralized Trials Because of Regulations?

February 12, 2021

As the COVID-19 pandemic first entered the states, the U.S. Food and Drug Administration (FDA) quickly recognized that the public health emergency would disrupt the conduct of clinical trials for medical products. New challenges arose…

The Importance of Diversity in Clinical Trials

January 28, 2021

In the world of clinical trials, uniformity can be a dirty word. From blind use of placebos to dosage variation, incorporation of variables is an essential part of any study. But it’s important for…

5 Essential Considerations for Global Clinical Trials

May 4, 2020

Over the past 10 years, the clinical trial industry has transformed dramatically. Globalization has taken off, giving rise to Contract Resource Organization (CRO) outsourcing, decentralized clinical trials, and overall greater transnational collaboration. Take a look…

Decentralized Trials

Fully Remote, Hybrid, or Flexible Hybrid Decentralized Trials

Start with ‘Why’ When Adopting New Tech to Support Hybrid Decentralized Trials

The The Future of RTSM: Insights and Forecasting with RTSM-Expert, Ian Davison:

Think Paper is the Safe Choice for Your Studies? Think Again.

Why CTMS Is Critical As Trial Complexities Increase

How to Sustain Clinical Trial Patient Engagement

How eSource Optimizes The Clinical Site Experience

The Power of Patient-Centricity in Rare Disease Studies

Can Your eClinical Empower Patients and Inform Stakeholders?

4 Reasons Decentralized Trials Are Here to Stay

How to Strengthen Trial Retention Through Patient Education

Thank Technology: Oncology’s Golden Age Is Here

Diseases Don’t Discriminate. So Why Aren’t Clinical Trials More Diverse?

How Decentralized Trials Strengthen Your Participation Pool

Hesitant to Embrace Decentralized Trials Because of Regulations?

The Importance of Diversity in Clinical Trials

5 Essential Considerations for Global Clinical Trials

COVID-19: The Catalyst for Change

How COVID-19 is Causing the Industry to Rethink Paper vs ePRO

Patient Diversity and eClinical Vendor Selection

How to Select the Ideal eClinical Service Provider for Oncology

Decentralized Trials: How Modern Tech Can Transform Your Trials

Decentralized Trials: How to Get Started

The Rise of Decentralized Trials

3 Ways Patient-Centricity Can Boost Clinical Trial ROI

3 Reasons Why eSource Is a Must for Global Trials

Patient Centricity: Greater Value for Participants and Beyond

5 Patient Engagement Innovations in Healthcare and Clinical Research

Decentralized Trials

Enter a topic, term or keyword below:

Subscribe to our mailing list